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Technical Briefs (-300 words text) summarize findings
that are of interest to a relatively limited audience. Read-
ers desiring fuller details may obtain them by writing
directly to the author(s) at the address given. Briefs deal-
ing with procedure or instrumentation intercomparisons,
evaluations, or improvements (including kit applications)
should be sent to Clinical Chemistry New8, 2029 K Street,
Washington, DC 20006.
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Fig. 1. Chromatogramsfor 1sls [Tyr#{176}j1-34PTHrP injected
onto(a)anoldC18column,(b)a new C18column,and(c)a newC18
column after treatment with BSA
The results in Figure la were obtained with a column that
had already been used in >300 protein and peptide purifi-
cations. When we replaced this with a new column from the
same manufacturer, there was a dramatic decrease in recov-
ery of the labeled peptide (Figure lb), as shown by the
absence of the 1-34 PTHrP peak at 29 mm. Such behavior
might be caused by strong or irreversible binding of peptide
(5). We suspected this was the case because no samples had
previously been injected onto this column.
To remove strong or irreversible binding sites from the
column, we applied a 10 g/L BSA solution at 1 mL/min for
3 h. Excess BSA and reversibly bound BSA were eluted
from the column through the use of several gradient cycles.
When radiolabeled 1-34 FFHrP was later injected onto the
BSA-treated column, a chromatogram was obtained simi-
lar to that seen on the old column (Figure lc). Fractions
collected from the peak eluting at 29 mm gave 42% binding
with a 40 000-fold dilution of the anti-(1--34 PTHrP) anti-
body, confirming the presence of active 1-34 PTHrP label.
Identical results were obtained on this column for at least
a year and 50 purifications of the 1-34 P’FHrP label,
indicating stable column behavior.
In summary, we obtained better recovery and more
reproducible chromatographic behavior for labeled 1-34
PTHrP with an albumin-pretreated reversed-phase column
than with a new, untreated reversed-phase column. This
treatment is simple and inexpensive and should be gener-
ally applicable for use in the purification of other radiola-
beled peptides and proteins.
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Reversed-phase high-performance liquid chromatogra-
phy (RP-HPLC) is an important tool in the purification of
radiolabeled peptides and proteins for immunoassay. How-
ever, for some proteins and peptides it is difficult to achieve
reproducible behavior in RP-HPLC because of the low
recovery of these compounds. Factors that can be varied to
improve recovery include the strength or pH of the mobile
phase, the chain length and spacing of groups on the
reversed-phase support, and the flow rate or steepness of
the elution gradient (1-5).
In this work, we found that pretreating reversed-phase
columns with albumin can also lead to improved recovery
of a radiolabeled peptide. This was noted in the purification
of lThIlabeled [Tyr#{176}]1-34parathyroid hormone (parathy-
rin)-related peptide (PTHrP). The [Tyr#{176}]1-34PTHrP was
obtained from Peninsula Labs (Belmont, CA). The peptide
was labeled by mixing 50 pL of 0.50 mol/L phosphate
buffer, pH 7.4, containing 2 ug of [Tyr#{176}]1-34PTHrP, with
1 pg of lodo-Gen (Pierce, Rockford, IL), adding 2000 pCi of
Nalsl, and reacting for 5 mm. The radiolabeled peptide
was initially purified on a 7 mm (i.d.) x 15 cm Bio-Gel P-2
size exclusion column (Bio-Rad, Richmond, CA), with 0.1
mol/L acetic acid containing 1 g of bovine serum albumin
(BSA) and 1 mL of Triton X-100 per liter as the eluent. The
label was stored at -20 #{176}Cuntil use. Incorporation of jas1
into the peptide by this procedure was 34 (± 5)% (n = 6).
Before using it in a P’FHrP immunoassay (6), we further
purified the labeled peptide by injecting 150 pL of the label
preparation onto a 4.1 mm (i.d.) x 30 cm Versapack C18
column (Ailtech, Deerfield, IL). The label was eluted from
the column at 1 mLmin by using a 40-mm gradient from
100% water containing trifluoroacetic acid (TFA), 1 g/L, to
a 60:40 (by vol) acetonitrile:water mixture, also contain-
ing 1 g of TFA per liter. A typical chromatogram obtained
under these conditions is shown in Figure la. The major
peak at 29 mm was identified as radiolabeled [Tyr#{176}]1-34
FFHrP, in agreement with results reported by the manu-
facturer for the unlabeled peptide under similar chromato-
graphic conditions. The activity of this peak was tested by
combining the label in this fraction with various dilutions
of RAS 6151N rabbit anti-(1--34 PTHrP) antibodies from
Peninsula Labs. An average of 60% binding occurred with
a 40 000-fold antibody dilution.
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Long-Term Storage of Salivary Cortisol Samples at
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Salivary cortisol concentration is an excellent indicator
of the plasma cortisol concentration (1). Collection of saliva
samples for the measurement of cortisol during space flight
provides a simple, noninvasive technique for studying the
change in adrenal function during the body’s adaptation to
weightlessness. However, during space flight the availabil-
ity of refrigerator space is limited. Therefore, we examined
several methods to determine the best way to preserve
saliva samples at room temperature.
HPLC analysis (2) of a cortisol standard added to saliva
and the direct radioimmunoasaay (RIA) (3) of endogenous
cortisol in saliva samples exhibited similar fractional do-
creases in cortisol concentrations as a function of time at
room temperature (data not shown). The HPLC analysis in
our laboratory indicated that the cortisol in the saliva was
not being enzymatically converted into cortisone (4). We
then tested several preserving agents, including acetic
acid, ascorbic acid, boric acid, and citric acid. According to
RIA, after 16 weeks of storage, the tubes containing acetic
acid or citric acid (each at 10 g/L) lost <20% of the total
cortisol, whereas the tubes without preservatives lost
>90% of the cortisol.
The Salivette (Sarstedt, Inc., Newton, NC), a saliva-
collection device containing a cotton swab, is used routinely
for collecting saliva samples in space flight experiments.
Citric acid-treated Salivettes were examined for their abil-
ity to preserve cortisol in saliva stored at room tempera-
ture. Sixteen subjects each provided three saliva samples:
two saliva samples were collected with untreated Sally-
ettes and the third was collected with a citric acid-treated
Salivette. One of the untreated Salivettes was stored frozen
as the control and the remaining untreated Salivette and
the citric acid-treated Salivette were stored at room tem-
perature for four to six weeks. The control salivary cortisol
concentration was 6.3 (SD 4.4) g/L (n = 16). The average
(SD) cortisol concentration in the samples stored at room
temperature was 4.3 (3.4) and 5.4 (3.6) p.gfL in the un-
treated and the citric acid-treated Salivettes, respectively.
The citric acid-treated Salivette not only preserved >85%
of the salivary cortisol, but also gave results that correlated
well (r = 0.95) with those for the freezer-stored samples
(Figure 1). In conclusion, the salivary cortisol was stable in
the presence of citric acid, 10 g/L, or preserved in a citric
acid-treated cotton swab for as long as six weeks at room
temperature.
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Fig. 1. Salivary cortisol stability: (top) correlation between frozen
salivasamplesandsamples stored at room temperature (r = 0.59);
(bottom) correlation between frozen sailva samplesand citric acid-
treated samples stored at room temperature (r = 0.95)
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Serum Camitine Quantification, Jan Cef ha”2 and Karel
Kithier2 (1 Damon Clin. Labs. at Detroit Med. Center,
and2 Dept. of Pathol., Wayne State Univ. School of Med.,
Detroit, MI 48201)
Moat methods used for carnitine quantification are based
on the transfer of an acetyl group from acetyl coenzyme A
(AcCoA) to carnitine by use of the enzyme carnitine ace-
tyltransferase (CAT; EC 2.3.1.7); either a radiochemical or
colorimetric method can be used. We have modified the
colorimetric method of Wieland et al. (1), which is based on
the reaction of 5,5’-dithiobis-2-nitrobenzoate (DTNB) with
free CoA released during the acetyl transfer (2), and
compared our results with those obtained by the original
method (1).
